Drug recall · October 11, 2023
HydrALAZINE Hydrochloride Tablets recall
Why: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11
- Lots / codes
Lot#: 1007002, Exp 12/31/2023
- Quantity
- 3,344 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- September 1, 2023 · Voluntary: Firm initiated
- Classified
- October 5, 2023
- Reported
- October 11, 2023
- Ended
- July 16, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydralazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.